CITED4 induces physiologic hypertrophy and promotes functional recovery after ischemic injury
The mechanisms by which exercise mediates its multiple cardiac benefits are only partly understood. Prior comprehensive analyses of the cardiac transcriptional components and microRNAs dynamically regulated by exercise suggest that the CBP/p300-interacting protein CITED4 is a downstream effector in both networks. While CITED4 has documented functional consequences in neonatal cardiomyocytes in vitro, nothing is known about its effects in the adult heart. To investigate the impact of cardiac CITED4 expression in adult animals, we generated transgenic mice with regulated, cardiomyocyte-specific CITED4 expression. Cardiac CITED4 expression in adult mice was sufficient to induce an increase in heart weight and cardiomyocyte size with normal systolic function, similar to the effects of endurance exercise training. After ischemia-reperfusion, CITED4 expression did not change initial infarct size but mediated substantial functional recovery while reducing ventricular dilation and fibrosis. Forced cardiac expression of CITED4 also induced robust activation of the mTORC1 pathway after ischemic injury. Moreover, pharmacological inhibition of mTORC1 abrogated CITED4's effects in vitro and in vivo. Together, these data establish CITED4 as a regulator of mTOR signaling that is sufficient to induce physiologic hypertrophy at baseline and mitigate adverse ventricular remodeling after ischemic injury.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:1 |
---|---|
Enthalten in: |
JCI insight - 1(2016), 9 vom: 16. Juni |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bezzerides, Vassilios J [VerfasserIn] |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 20.11.2019 published: Print Citation Status Publisher |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM262542005 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM262542005 | ||
003 | DE-627 | ||
005 | 20231224201959.0 | ||
007 | tu | ||
008 | 231224s2016 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0875.xml |
035 | |a (DE-627)NLM262542005 | ||
035 | |a (NLM)27430023 | ||
035 | |a (PII)e85904 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bezzerides, Vassilios J |e verfasserin |4 aut | |
245 | 1 | 0 | |a CITED4 induces physiologic hypertrophy and promotes functional recovery after ischemic injury |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Revised 20.11.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status Publisher | ||
520 | |a The mechanisms by which exercise mediates its multiple cardiac benefits are only partly understood. Prior comprehensive analyses of the cardiac transcriptional components and microRNAs dynamically regulated by exercise suggest that the CBP/p300-interacting protein CITED4 is a downstream effector in both networks. While CITED4 has documented functional consequences in neonatal cardiomyocytes in vitro, nothing is known about its effects in the adult heart. To investigate the impact of cardiac CITED4 expression in adult animals, we generated transgenic mice with regulated, cardiomyocyte-specific CITED4 expression. Cardiac CITED4 expression in adult mice was sufficient to induce an increase in heart weight and cardiomyocyte size with normal systolic function, similar to the effects of endurance exercise training. After ischemia-reperfusion, CITED4 expression did not change initial infarct size but mediated substantial functional recovery while reducing ventricular dilation and fibrosis. Forced cardiac expression of CITED4 also induced robust activation of the mTORC1 pathway after ischemic injury. Moreover, pharmacological inhibition of mTORC1 abrogated CITED4's effects in vitro and in vivo. Together, these data establish CITED4 as a regulator of mTOR signaling that is sufficient to induce physiologic hypertrophy at baseline and mitigate adverse ventricular remodeling after ischemic injury | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Platt, Colin |e verfasserin |4 aut | |
700 | 1 | |a Lerchenmüller, Carolin |e verfasserin |4 aut | |
700 | 1 | |a Paruchuri, Kaavya |e verfasserin |4 aut | |
700 | 1 | |a Oh, Nul Loren |e verfasserin |4 aut | |
700 | 1 | |a Xiao, Chunyang |e verfasserin |4 aut | |
700 | 1 | |a Cao, Yunshan |e verfasserin |4 aut | |
700 | 1 | |a Mann, Nina |e verfasserin |4 aut | |
700 | 1 | |a Spiegelman, Bruce M |e verfasserin |4 aut | |
700 | 1 | |a Rosenzweig, Anthony |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t JCI insight |d 2016 |g 1(2016), 9 vom: 16. Juni |w (DE-627)NLM257703918 |x 2379-3708 |7 nnns |
773 | 1 | 8 | |g volume:1 |g year:2016 |g number:9 |g day:16 |g month:06 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 1 |j 2016 |e 9 |b 16 |c 06 |